Lincoln Pharmaceuticals Limited
LINCOLN · NSE · ₹582 a share (close of 01 Oct 2026)
Available company data, source links and archived checks for Lincoln Pharmaceuticals Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Revenue rose 15.1%; Net profit was ₹36.23 crore.
Quarter ended 2026-06-30 · consolidated · Company filing
Recorded quarterly figures
| Quarter | Revenue / income | YoY |
Profit | YoY | Net margin | Source |
|---|
| Jun 2026 | Revenue: ₹177 cr | +15.1% | Net profit: ₹36 cr | +30.9% | 20.4% | Company filing source |
| Mar 2026 | Revenue: ₹187 cr | +11.4% | Net profit: ₹12 cr | +0.5% | 6.2% | Company filing source |
| Dec 2025 | Revenue: ₹166 cr | — | Net profit: ₹29 cr | — | 17.2% | Company filing source |
| Sep 2025 | Revenue: ₹163 cr | — | Net profit: ₹20 cr | — | 12.2% | Company filing source |
| Jun 2025 | Revenue: ₹154 cr | +4.6% | Net profit: ₹28 cr | +16.9% | 18.0% | Company filing source |
| Mar 2025 | Revenue: ₹168 cr | — | Net profit: ₹12 cr | — | 6.9% | Company filing source |
YoY means change from the same quarter a year earlier.
— means no comparable figure is available. Older entries with incomplete source
details have not been revalidated under the current checks.
Who holds it — from the filings
Munjal Mahendrabhai Patel 13.4%Ashish Rajanikant Patel 10.6%Rajanikant Gulabdas Patel 3.8%Mahendrabhai Gulabdas Patel 3.4%Sunmed Corporation Llp 2.5%register as filed
2026-06-30
Filing timeline — what the company told the exchange
- Shareholders meeting. Lincoln Pharmaceuticals Limited has informed the Exchange a copy of Voting Results of Annual General Meeting held on September 30, 2026.…
03 Oct 2026 · document
- Shareholders meeting. Lincoln Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026…
30 Sep 2026 · document
- Change in Management. Lincoln Pharmaceuticals Limited has informed the Exchange about change in Management…
24 Sep 2026 · document
- Change in Management. Lincoln Pharmaceuticals Limited has informed the Exchange about change in Management…
24 Sep 2026 · document
- Lincoln Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 20…
23 Sep 2026 · document
- Lincoln Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication for Notice of 32nd Annual General Meeting.…
07 Sep 2026 · document
- Updates. Lincoln Pharmaceuticals Limited has informed the Exchange Intimation regarding dispatch of physical communication to the Shareholders who have not regi…
05 Sep 2026 · document
- Shareholders meeting. Lincoln Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026.…
05 Sep 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time